La dilatation des bronches chez l’enfant : expérience sur une période de dix ans

Siham ZOUITER

Résumé


La dilatation des bronches ou bronchectasie est une pathologie fréquente dans les pays en voie de développement. Les étiologies sont très nombreuses. La dilatation des bronches est sous diagnostiquée et mal explorée et constitue une cause de morbidité et de mortalité considérable en milieu pédiatrique. Cet article fait le point sur notre expérience en matière de prise en charge des dilatations des bronches chez l’enfant avec comme objectif d’analyser les particularités épidémiologiques, cliniques et étiologiques des patients. Nous avons mené une étude rétrospective incluant 131 cas de dilatations de bronches colligés au service des maladies infectieuses et d’immunologie clinique à l’hôpital Mère-Enfant A. Harouchi au CHU Ibn Rochd de Casablanca, durant une période de 10 ans (2010 à 2020). La moyenne d’âge était de 8,7 ans avec un sex ratio de 0,84. Les signes fonctionnels étaient dominés par la toux chronique ou récidivante (64,88%). L’étiologie a été identifiée dans 65,64% des cas. La prise en charge était basée sur un traitement médical incluant une kinésithérapie respiratoire, une antibiothérapie et un traitement étiologique. La chirurgie a été réalisée chez quatorze patients

Mots-clés


Dilatation des bronches, bronchectasie, Enfant.

Texte intégral :

PDF

Références


Laennec R, Forbes JS. A Treatise on the Diseases of the Chest,

and on Mediate Auscultation. The Medico-Chirurgical Review.

;10(20):420-422.

Barker AF, Bardana EJ. Bronchiectasis: Update of an Orphan

Disease. Am Rev Respir Dis. 1988;137(4):969‑978.

Ringshausen FC, de Roux A, Pletz MW, Hämäläinen N, Welte

T, Rademacher J. Bronchiectasis-Associated Hospitalizations

in Germany, 2005–2011: a Population-Based Study of Disease

Burden and Trends. PloS One. 2013;8(8): e71109.

Haya Al Subie and Dominic A Fitzgerald. Non-cystic fibrosis

bronchiectasis. Journal of Paediatrics and Child Health. 2012;48:

–388.

Clark NS. Bronchiectasis in childhood. Br Med J. 1963;1:80-88.

Field CE. Bronchiectasis in childhood; clinical survey of 160

cases. Pediatrics. 1949;4(1):21-46.

Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand national

incidence of bronchiectasis "too high" for a developed country.

Arch Dis Child. 2005;90:737-740.

Bouyahia O, Essadem L, Matoussi N, Gharsallah L, Fitouri Z,

Mrad Mazigh S and al. Etiology and outcome of bronchiectasis

in children: a study of 41 patients. Tunis Med. 2008;86:996–999

Oujidi B, Berrabah Y. Les étiologies des dilatations de bronches

chez l’enfant : à propos de 44 cas. Revue des maladies respiratoires.

;34:A257.

Banjar HH. A review ef 151 cases of pediatric non cystic fibrosis

bronchiectasis in tertiary care center. Ann Thoracic Medicine.

;2(1):3-8.

Karadag B. F. Karakoc R. Ersu A. Kut S. Bakac E. Dagli. NonCystic-Fibrosis

Bronchiectasis in Children: A Persisting Problem

in Developing Countries. Respiration. 2005;72(3):233-238.

Nike I. Beckeringh, Niels W. Rutjes, Joost van Schuppen, Taco

W. Kuijpers. Noncystic Fibrosis Bronchiectasis: Evaluation

of an extensive diagnostic protocol in determining pediatric

lung disease. Ogy Phd1. Pediatric Allergy Immunol Pulmonol.

;32(4):155-162.

Guran T, Ersu R, Karadag B, Karakoc F and al. Withdrawal

of inhaled steroids in children with non-cystic fibrosis bronchiectasis.

Journal of Clinical Pharmacy and Therapeutics.

;33:603–611.

Hyoung-Young Kim, Ji-Won Kwon, Juhee Seo . Allergy Asthma

Immunol Res. 2011;3(1): 39-45.

Eun Leea, Jung Yeon Shimb, Hyung Young Kim. Clinical

characteristics and etiologies of bronchiectasis in Korean children:

A multicenter retrospective study. Respiratory Medicine.

;150:8-14.

EL Alaoui EL Hanafi Mounia. Dilatation des bronches chez l’enfant

: étude rétrospective de 100 cas. Thèse de médecine n°311

Casablanca 2009.

Ekstrom BG, Dance S, Low DE, Fagley RE. Successful

Airway Management in a Patient with Severe Proximal Achalasia

Requires Interdisciplinary Cooperation. A A Case Rep.

;3(11):153-155.

King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW.

Characterisation of the onset and presenting clinical features of

adult bronchiectasis. Respir Med. 2006;100: 2183-2189.

Altenburg J, Wortel K, van der Werf TS, Boersma WG. Noncystic

fibrosis bronchiectasis: clinical presentation, diagnosis and

treatment, illustrated by data from a Dutch Teaching Hospital.

Neth J Med. 2015;73: 147-154.

Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL,

Hazucha M, et al. Dyskinésie ciliaire primitive: caractéristiques

diagnostiques et phénotypiques. Suis J Respir Crit Care Med.

; 169: 459-467.

Dogru D, Nik-Ain A, Kiper N, Gocmen A, Ozcelik U. Bronchiectasis:

the consequence of late diagnosis in chronic respiratory

symptoms. J Trop Pediatr. 2005 ;51:362–365.

Chang AB, Marchant JM. Protracted bacterial bronchitis is

a precursor for bronchiectasis in children: myth or maxim.

Breathe.2019; 15: 167–170.

Brinchault G, Morel V, Meunier C, Belleguic C, Delaval P. Dilatation

des bronches. EMC-Médecine. 2004:131-140.

Haya Al Subie, Dominic A Fitzgerald. Non-cystic fibrosis bronchiectasis.

Journal of Paediatrics and Child Health. 2012:48;382–

Ben Khaled M, Ouederni M, Ben Fradj I, Rhouma K, Rekaya S,

Dhouib N, et al. Le retard statural et déficits immunitaires primitifs

: fréquence et facteurs de risque dans une série tunisienne.

Ann Endocrinol. 2016;77(4):318.

Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou

K, De Soyza A and al. Etiology of non-cystic fibrosis bronchiectasis

in adults and its correlation to disease severity. Ann Am

Thorac Soc. 2015;12:1764-1770.

Milliron B, Henry TS, Veeraraghavan S, Little BP. Bronchiectasis:

mechanisms and imaging clues of associated common and

uncommon diseases. Radiogr Rev Publ Radiol Soc N Am Inc.

;35:1011-1030.

Chassagnon G, Brun AL, Benani S et al. Imagerie des dilatations

des bronches. Revue de Pneumologie Clinique. 2018;74 :299-

Chang-Macchiu P, Traversi L ,Polverino E and al. Bronchiectasis

phenotypes. Current Opinion in Pulmonary Medicine.2019;25:281-288.

Zaid AA, Elnazir B, Greally P. A decade of non-cystic fibrosis

bronchiectasis 1996-2006. Ir Med J.2010;103:77–9.

Santamaria F, Montella S, Pifferi M, Ragazzo V, De Stefano S,

De Paulis N, Maglione M, Boner AL. A descriptive study of

non cystic fibrosis bronchiectasis in a pediatric population from

central and southern Italy. Respiration. 2009;77:160-165.

Wurzel DF, Mackay IM, Marchant JM, Wang CY, Yerkovich ST,

Upham JW, Smith-Vaughan HC, Petsky HL. Adenovirus species

C is associated with chronic suppurative lung diseases in children.

Clin Infect Dis. 2014;59:34-40.

Anne B Chang, Andrew Bush, Keith Grimwood. Bronchiectasis

in children: diagnosis and treatment. Lancet. 2018;392:866–879.

Shrestha L, Basnet S, Kanskar P. Bronchiectasis in a positive

HIV child: a case report. Journal of Institute of Medicine.

;35:74-77.

Xi-Ling Wu, Lei Wu, Zhi-Min Chen. Unusual Bronchial Foreign

Bodies with Localized Bronchiectasis in Five Children. Case

Reports in Medicine. 2019;2019: 4143120.

Kim HY, Kwon JW, Seo J, Song YH, Kim BJ, Yu J and al. Bronchiectasis

in children: 10-year experience at a single institution.

Allergy Asthma Immunol Res.2011;3:39–45.

Karakoc F, Karadag B, Akbenlioglu C and al. Foreign body aspiration:

what is the outcome. Pediatr Pulmonol.2002;34:30-36.

Abdurrahman Erdem Başaran, Ayşen Başaran. Evaluation of

Noncystic Fibrosis Bronchiectasis Using Clinical and Radiological

Scorings in Children. Turk Thorac J. 2018;19:159-164.

Sethi GR, Batra V. Bronchiectasis: Causes and management.

Indian J Pediatr. 2000;67:133-139.

Rev Mar Mal Enf 2022; 51 : 16-21 20

King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis.

Intern Med J. 2006;36:729–737.

Nathan Am, Muthusamy A, Thavagnanam S, Hashim A,

De Bruyne J. Chronic suppurative lung disease in a developing

country: impact on child and parent. Pediatr Pulmonol.

;49:435-440.

Escudier E, Tamalet A, Prulière-Escabasse V et coll. Dyskinésie

ciliaire primitive. Rev Fr Allergol Immunol Clin. 2006;46:530-

Mohammad Esmaeili , Marjan Esmaeili, Seyed Javad Sayedi,

Mohammad Ali Kiani. Alpha- 1 Antitrypsin Deficiency in Children:

Pulmonary Involvement. International Journal of Pediatrics.2015;3:459-465.

Eastham KM, Fall AJ, Mitchell L and al. The need to redefine

non-cystic fibrosis bronchiectasis in childhood. Thorax.

;59:324-327.

Wen Li, Zhong Qin, Jie Gao, Zhibin Jiang, Yihui Chai, Liancheng

Guan and Yunzhi Chen. Azithromycin or erythromycin. Macrolides

for non-cystic fibrosis bronchiectasis in adults: A systematic

review and adjusted indirect treatment comparison. Chronic

Respiratory Disease. 2018;16:1-9.

El Boustany P, Gachelin| E, Colomban C , Cernoia J. A review of

non-cystic fibrosis bronchiectasis in children with a focus on the

role of long-term treatment with macrolides. Pediatric Pulmonology.

;54:487-496.

Quon BS, Goss CH, Ramsey BW. Inhaled Antibiotics for lower

airway infections. Ann Am Thorac Soc. 2014;11:425-434

Wall LA ,Wisner EL ,Gipson KS, Ricardo S. Bronchiectasis in

Primary Antibody Deficiencies: A Multidisciplinary Approch

Publisher. Frontiers in Immunology. 2020;11:522.

Munck A. Nutrition et mucoviscidose : de la prise en charge

préventive au support nutritionnel. Nutrition Clinique et Métabolisme.

;28:12-16.

Eun Lee, Soo-Jong Hong. Pharmacotherapeutic strategies for

treating bronchiectasis in pediatric patients. Expert Opinion on

Pharmacotherapy. 2019 ;20 :1025-1036.


Renvois

  • Il n'y a présentement aucun renvoi.


Bookmark and Share